Q2 2010

Filed Aug 20, 2010 · 10-Q · 51 days after period end · 0000912282-10-000727

Q2 2010 · 10-Q

Revenue—

Net Income

-$1.38K

no prior Q2 2009 on file

EPS Diluted

$0.00

no prior Q2 2009 on file

Operating Income-$385,627—

Operating Cash Flow-$289,549—

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 20, 2010 · 51 d after period end

CTT Pharmaceutical Holdings, Inc. · CIK 1035422 · Engraved from SEC EDGAR